FIGURE 3.

Dynamic changes in arterial blood gas parameters and methemoglobin levels following treatment. (A) Initial arterial blood gas analysis performed on March 10, 2026 before treatment, demonstrating severe methemoglobinemia with a marked oxygen saturation gap. (B) Repeat arterial blood gas analysis on March 11, 2026 after the first administration of methylene blue, showing a marked decrease in methemoglobin level. (C) Follow-up arterial blood gas analysis on March 12, 2026 demonstrating normalization of methemoglobin level and improvement in oxygenation.